
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-03-04-2015
- Volume 11
- Issue 3
PCI Completes Full Biotec Rebranding
Five months after PCI acquired Biotec International Services , PCI has completed a complete rebranding of the UK-based Biotec.
In September 2014, PCI
Biotec brings PCI a variety of services including manufacturing, packaging, and labeling, consultancy services, global distribution, returned drug management, global logistics planning, as well as a wide range of temperature storage management from controlled ambient to -196 °C. Biotec recently announced that it expanded its facilities in Bridgend to include more clinical-trial packaging and distribution services as well as increased cold-chain capabilities to support a wider range of medicines from +25 °C to -196 °C.
“The rebranding of Biotec demonstrates to the global pharmaceutical community that by joining the PCI group, we are able to offer a significantly increased global capacity to deliver a worldwide offering to our clients across a wider range of services, while staying true to our core values of expertise, customer service, efficiency, and flexibility,” said Dr. Fiona Withey, managing director, UK Clinical Services, PCI, in a press release.
Source:
Articles in this issue
over 11 years ago
Grand River Names Director of Manufacturingover 11 years ago
WellSpring Pharma Services Names New Presidentover 11 years ago
Repligen Expands US Manufacturing Facilityover 11 years ago
PBOA Supports Legislation to Protect FDA User Feesover 11 years ago
Novasep to Manufacture Celladon's Mydicar APIover 11 years ago
Modest Expectations for CMOs and Biosimilarsover 11 years ago
FDA Tightens Drug Security Regulationsover 11 years ago
Mitigating Cold-Chain Risksover 11 years ago
The Challenge of Resolving Agents for Chiral Resolutionover 11 years ago
Catalent Expands Clinical Packaging Capabilities in Europe



